Arienne Mirmiran Selected Research

Arienne Mirmiran Research Topics

3	Acute Intermittent Porphyria (Porphyria, Acute) 01/2022 - 01/2018
2	Chronic Renal Insufficiency 01/2022 - 07/2021
2	Erythropoietic Protoporphyria 01/2019 - 04/2014
1	Injection Site Reaction 01/2022
1	Fatigue 01/2022
1	Nausea 01/2022
1	Hyperhomocysteinemia 01/2022
1	Erythropoietic Porphyria (Congenital Erythropoietic Porphyria) 11/2021
1	Acute Erythroblastic Leukemia (Erythroleukemia) 04/2020
1	Porphyrias (Porphyria) 11/2019
1	Sideroblastic Anemia 11/2019
1	X-linked sideroblastic anemia 11/2019
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2019
1	Papillary Thyroid Cancer 02/2012
1	Neoplasms (Cancer) 02/2012

3	Aminolevulinic Acid (Levulan)FDA Link 01/2022 - 11/2019
3	Heme (Haem)IBA 01/2022 - 01/2018
2	givosiranIBA 01/2022 - 07/2021
2	EnzymesIBA 07/2021 - 11/2019
2	LigandsIBA 04/2020 - 01/2019
2	Ferrochelatase (Heme Synthetase)IBA 01/2019 - 04/2014
1	Alanine Transaminase (SGPT)IBA 01/2022
1	HomocysteineIBA 01/2022
1	IronIBA 11/2021
1	PorphyrinsIBA 11/2021
1	AcidsIBA 04/2020
1	PK 11195 (PK11195)IBA 04/2020
1	protoporphyrin IXIBA 04/2020
1	Proteins (Proteins, Gene)FDA Link 04/2020
1	Pharmaceutical PreparationsIBA 04/2020
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 11/2019
1	succinyl-coenzyme A (succinyl-CoA)IBA 11/2019
1	Peptides (Polypeptides)IBA 01/2019
1	Hydroxymethylbilane Synthase (Porphobilinogen Deaminase)IBA 01/2018
1	Antisense OligonucleotidesIBA 04/2014
1	SurvivinIBA 02/2012

1	Precision Medicine 01/2022
1	Therapeutics 04/2014